Johnson & Johnson Share Price Bolsa De Valores De Colombia

Equities

JNJ

US4781601046

Pharmaceuticals

End-of-day quote Bolsa De Valores De Colombia 03:30:00 14/05/2024 am IST 5-day change 1st Jan Change
5,87,980 COP +1.12% Intraday chart for Johnson & Johnson +1.12% -3.40%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 8.84TCr 3,37,48200Cr 7,37100Cr Sales 2025 * 9.08TCr 3,46,68600Cr 7,57200Cr Capitalization 37TCr 14,03,18100Cr 30,64700Cr
Net income 2024 * 2.2TCr 84,16500Cr 1,83800Cr Net income 2025 * 2.31TCr 88,18700Cr 1,92600Cr EV / Sales 2024 * 4.08 x
Net cash position 2024 * 699.71Cr 26,72100Cr 58TCr Net cash position 2025 * 2.11TCr 80,48300Cr 1,75800Cr EV / Sales 2025 * 3.82 x
P/E ratio 2024 *
17 x
P/E ratio 2025 *
16 x
Employees 1,31,900
Yield 2024 *
3.16%
Yield 2025 *
3.3%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.12%
1 week+1.12%
Current month+2.48%
1 month+3.13%
3 months-4.46%
6 months-1.35%
Current year-3.40%
More quotes
1 week
581 460.00
Extreme 581460
587 980.00
1 month
570 160.00
Extreme 570160
587 980.00
Current year
570 160.00
Extreme 570160
639 160.00
1 year
570 160.00
Extreme 570160
740 610.00
3 years
570 160.00
Extreme 570160
898 270.00
5 years
413 020.00
Extreme 413020
898 270.00
10 years
187 540.00
Extreme 187540
898 270.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/89/01
Director of Finance/CFO 57 01/98/01
Chief Tech/Sci/R&D Officer 58 05/19/05
Members of the board TitleAgeSince
Director/Board Member 70 25/19/25
Director/Board Member 72 19/14/19
Director/Board Member 70 22/09/22
More insiders
Date Price Change Volume
14/24/14 5,87,980 +1.12% 5
10/24/10 5,81,460 0.00% 0
09/24/09 5,81,460 0.00% 0
08/24/08 5,81,460 0.00% 0
07/24/07 5,81,460 0.00% 23

End-of-day quote Bolsa De Valores De Colombia, May 14, 2024

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
152.7 USD
Average target price
173.3 USD
Spread / Average Target
+13.49%
Consensus
1st Jan change Capi.
+31.37% 59TCr
+20.83% 33TCr
+5.69% 29TCr
+14.83% 24TCr
+9.93% 21TCr
-6.95% 20TCr
+10.77% 17TCr
+0.10% 16TCr
+0.89% 12TCr
Other Pharmaceuticals
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW